Effect of neonatal exposure to genistein on bone metabolism in mice at adulthood

Pediatric Research

Volumn 61, Issue 1, 2007, Pages 48-53

  Piekarz, Ana V ^a   Ward, Wendy E ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DIETHYLSTILBESTROL; GENISTEIN;

ADULTHOOD; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE DENSITY; BONE METABOLISM; CONTROLLED STUDY; DISEASE RESISTANCE; DRUG EFFECT; ESTROGEN ACTIVITY; FEMALE; FEMUR; FRACTURE; LUMBAR VERTEBRA; MALE; MOUSE; NEWBORN; NEWBORN PERIOD; NONHUMAN; PRIORITY JOURNAL; RANDOMIZATION; WEANING; ANIMAL; BONE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; METABOLISM; RANDOMIZED CONTROLLED TRIAL;

ANIMALS; ANIMALS, NEWBORN; BONE AND BONES; BONE DENSITY; FEMALE; FRACTURES, BONE; GENISTEIN; MALE; MICE;

EID: 33846950426     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/01.pdr.0000250200.94611.03     Document Type: Article

References (48)

1. Migliaccio S, Newbold RR, Bullock BC, Jefferson WJ, Sutton FG Jr, McLachlan JA, Korach KS 1996 Alterations of maternal estrogen levels during gestation affect the skeleton of female offspring. Endocrinology 137:2118-2125
2. Migliaccio S, Newbold RR, Teti A, Jefferson WJ, Toverud SU, Taranta A, Bullock BC, Suggs CA, Spera G, Korach KS 2000 Transient estrogen exposure of female mice during early development permanently affects osteoclastogenesis in adulthood. Bone 27:47-52
3. Setchell KD, Zimmer-Nechemias L, Cai J, Heubi JE 1997 Exposure of infants to phyto-oestrogens from soy-based infant formula. Lancet 350:23-27
4. American Academy of Pediatrics, Committee on Nutrition 1998 Soy protein-based formulas: recommendations for use in infant feeding. Pediatrics 101:148-153.
5. Steichen JJ, Tsang RC 1987 Bone mineralization and growth in term infants fed soy-based or cow milk-based formula. J Pediatr 110:687-692
6. Mei J, Yeung SS, Kung AW 2001 High dietary phytoestrogen intake is associated with higher bone mineral density in postmenopausal but not premenopausal women. J Clin Endocrinol Metab 86:5217-5221
7. Horiuchi T, Onouchi T, Takahashi M, Ito H, Orimo H 2000 Effect of soy protein on bone metabolism in postmenopausal Japanese women. Osteoporos Int 11:721-724
8. Ho SC, Chan SG, Yi Q, Wong E, Leung PC 2001 Soy intake and the maintenance of peak bone mass in Hong Kong Chinese women. J Bone Miner Res 16:1363-1369
9. Morabito N, Crisafulli A, Vergara C, Gaudio A, Lasco A, Frisina N, D'Anna R, Corrado F, Pizzoleo MA, Cincotta M, Altavilla D, Ientile R, Squadrito F 2002 Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: a randomized double-blind placebo-controlled study. J Bone Miner Res 17:1904-1912
10. Potter SM, Baum JA, Teng H, Stillman RJ, Shay NF, Erdman JW Jr 1998 Soy protein and isoflavones: their effects on blood lipids and bone density in postmenopausal women. Am J Clin Nutr 68:1375S-1379S
11. Alekel DL, Germain AS, Peterson CT, Hanson KB, Stewart JW, Toda T 2000 Isoflavone-rich soy protein isolate attenuates bone loss in the lumbar spine of perimenopausal women. Am J Clin Nutr 72:844-852
12. Atkinson C, Compston JE, Day NE, Dowsett M, Bingham SA 2004 The effects of phytoestrogen isoflavones on bone density in women: a double-blind, randomized, placebo-controlled trial. Am J Clin Nutr 79:326-333
13. Anderson JJ, Ambrose WW, Garner SC 1998 Biphasic effects of genistein on bone tissue in the ovariectomized, lactating rat model. Proc Soc Exp Biol Med 217:345-350
14. Fanti P, Monier-Faugere MC, Geng Z, Schmidt J, Morris PE, Cohen D, Malluche HH 1998 The phytoestrogen genistein reduces bone loss in short-term ovariectomized rats. Osteoporos Int 8:274-281
15. Ishimi Y, Miyaura C, Ohmura M, Onoe Y, Sato T, Uchiyama Y, Ito M, Wang X, Suda T, Ikegami S 1999 Selective effects of genistein, a soybean isoflavone, on B-lymphopoiesis and bone loss caused by estrogen deficiency. Endocrinology 140:1893-1900
16. Arjmandi BH, Birnbaum R, Goyal NV, Getlinger MJ, Juma S, Alekel L, Hasler CM, Drum ML, Hollis BW, Kukreja SC 1998 Bone-sparing effect of soy protein in ovarian hormone-deficient rats is related to its isoflavone content. Am J Clin Nutr 68:1364S-1368S.
17. Arjmandi BH, Getlinger MJ, Goyal NV, Alekel L, Hasler CM, Juma S, Drum ML, Hollis BW, Kukreja SC 1998 Role of soy protein with normal or reduced isoflavone content in reversing bone loss induced by ovarian hormone deficiency in rats. Am J Clin Nutr 68:1358S-1363S.
18. Picherit C, Coxam V, Bennetau-Pelissero C, Kati-Coulibaly S, Davicco MJ, Lebecque P, Barlet JP 2000 Daidzein is more efficient than genistein in preventing ovariectomy-induced bone loss in rats. J Nutr 130:1675-1681
19. Picherit C, Bennetau-Pelissero C, Chanteranne B, Lebecque P, Davicco MJ, Barlet JP, Coxam V 2001 Soybean isoflavones dose-dependently reduce bone turnover but do not reverse established osteopenia in adult ovariectomized rats. J Nutr 131:723-728
20. Picherit C, Chanteranne B, Bennetau-Pelissero C, Davicco MJ, Lebecque P, Barlet JP, Coxam V 2001 Dose-dependent bone-sparing effects of dietary isoflavones in the ovariectomised rat. Br J Nutr 85:307-316
21. Setchell KD, Cassidy A 1999 Dietary isoflavones: biological effects and relevance to human health. J Nutr 129:758S-767S.
22. Chagin AS, Lindberg MK, Andersson N, Moverare S, Gustafsson JA, Savendahl L, Ohlsson C 2004 Estrogen receptor-beta inhibits skeletal growth and has the capacity to mediate growth plate fusion in female mice. J Bone Miner Res 19:72-77
23. Hillisch A, Peters O, Kosemund D, Muller G, Walter A, Schneider B, Reddersen G, Elger W, Fritzemeier KH 2004 Dissecting physiological roles of estrogen receptor alpha and beta with potent selective ligands from structure-based design. Mol Endocrinol 18:1599-1609
24. Lee K, Jessop H, Suswillo R, Zaman G, Lanyon L 2003 Endocrinology: bone adaptation requires oestrogen receptor-alpha. Nature 424:389-
25. Lee KC, Jessop H, Suswillo R, Zaman G, Lanyon LE 2004 The adaptive response of bone to mechanical loading in female transgenic mice is deficient in the absence of oestrogen receptor-alpha and -beta. J Endocrinol 182:193-201
26. Reeves PG 1997 Components of the AIN-93 diets as improvements in the AIN-76A diet. J Nutr 127:838S-841S.
27. Jefferson WN, Newbold RR 2000 Potential endocrine-modulating effects of various phytoestrogens in the diet. Nutrition 16:658-662
28. Canadian Council on Animal Care 1993 Guide to the Care and Use of Experimental Animals, Ottawa, ON, pp 1-211.
29. Fonseca D, Ward WE 2004 Daidzein together with high calcium preserve bone mass and biomechanical strength at multiple sites in ovariectomized mice. Bone 35:489-497
30. Ealey KN, Fonseca D, Archer MC, Ward WE Bone abnormalities in adolescent leptin-deficient mice. Regul Pept 136:9-13.
31. Barker DJ 2003 The developmental origins of adult disease. Eur J Epidemiol 18:733-736
32. Barker DJ 2004 Developmental origins of adult health and disease. J Epidemiol Community Health 58:114-115
33. Barker DJ 2004 The developmental origins of adult disease. J Am Coll Nutr 23:588S-595S.
34. Lucas A 1998 Programming by early nutrition: an experimental approach. J Nutr 128:401S-406S.
35. Young LE 2001 Imprinting of genes and the Barker hypothesis. Twin Res 4:307-317
36. Chang H, Jin TY, Jin WF, Gu SZ, Zhou YF 2003 Modulation of isoflavones on bone-nodule formation in rat calvaria osteoblasts in vitro. Biomed Environ Sci 16:83-89
37. Jia TL, Wang HZ, Xie LP, Wang XY, Zhang RQ 2003 Daidzein enhances osteoblast growth that may be mediated by increased bone morphogenetic protein (BMP) production. Biochem Pharmacol 65:709-715
38. Morris C, Thorpe J, Ambrosio L, Santin M 2006 The soybean isoflavone genistein induces differentiation of MG63 human osteosarcoma osteoblasts J Nutr 136:1166-1170
39. Soung DY, Devareddy L, Khalil DA, Hooshmand S, Patade A, Lucas EA, Arjmandi BH 2006 Soy affects trabecular microarchitecture and favorably alters select bone-specific gene expressions in a male rat model of osteoporosis. Calcif Tissue Int 78:385-391
40. Sliwinski L, Folwarczna J, Janiec W, Grynkiewicz G, Kuzyk K 2005 Differential effects of genistein, estradiol and raloxifene on rat osteoclasts in vitro. Pharmacol Rep 57:352-359
41. Gao YH, Yamaguchi M 2000 Suppressive effect of genistein on rat bone osteoclasts: involvement of protein kinase inhibition and protein tyrosine phosphatase activation. Int J Mol Med 5:261-267
42. Chen WF, Wong MS 2006 Genistein modulates the effects of parathyroid hormone in human osteoblastic SaOS-2 cells. Br J Nutr 95:1039-1047
43. Jefferson WN, Padilla-Banks E, Newbold RR 2005 Adverse effects on female development and reproduction in cd-1 mice following neonatal exposure to the phytoestrogen genistein at environmentally relevant doses. Biol Reprod 73:798-806
44. McLachlan JA, Newbold RR, Bullock BC 1980 Long-term effects on the female mouse genital tract associated with prenatal exposure to diethylstilbestrol. Cancer Res 40:3988-3999
45. Goyal HO, Robateau A, Braden TD, Williams CS, Srivastava KK, Ali K 2003 Neonatal estrogen exposure of male rats alters reproductive functions at adulthood. Biol Reprod 68:2081-2091
46. Herbst AL 1999 Diethylstilbestrol and adenocarcinoma of the vagina. Am J Obstet Gynecol 181:1576-1578
47. Strom BL, Schinnar R, Ziegler EE, Barnhart KT, Sammel MD, Macones GA, Stallings VA, Drulis JM, Nelson SE, Hanson SA 2001 Exposure to soy-based formula in infancy and endocrinological and reproductive outcomes in young adulthood. JAMA 286:807-814
48. Jefferson WN, Couse JF, Padilla-Banks E, Korach KS, Newbold RR 2002 Neonatal exposure to genistein induces estrogen receptor (ER)alpha expression and multioocyte follicles in the maturing mouse ovary: evidence for ERbeta-mediated and nonestrogenic actions. Biol Reprod 67:1285-1296